Business Weekly

Thursday
May 15th
  • Login
  • Sign up
    Registration


    Fields marked with an asterisk (*) are required.
    Security Code: * This Field is required This Field IS visible on profile Information for: Security Code: : Enter Security Code from image
    Weekly digest
    Receive HTML?
    Name: * This Field is required This Field IS NOT visible on profile
    Username: * This Field is required This Field IS visible on profile Information for: Username: : Please enter a valid User Name.  No spaces, more than 2 characters and contain 0-9,a-z,A-Z
    E-mail: * This Field is required This Field IS NOT visible on profile Information for: E-mail: : Please enter a valid e-mail address.
    Password: * This Field is required This Field IS NOT visible on profile Information for: Password: : Please enter a valid Password.  No spaces, more than 6 characters and contain 0-9,a-z,A-Z
    Verify Password: * This Field is required This Field IS NOT visible on profile
    Company: * This Field is required This Field IS visible on profile
    Industry Sector: * This Field is required This Field IS visible on profile Information for: Industry Sector : Please choose one industry sector from the drop-down box.
    Address: This Field IS visible on profile
    City: This Field IS visible on profile
    Postal Code: This Field IS visible on profile
    Country: This Field IS visible on profile
    Phone #: This Field IS visible on profile
    Website: This Field IS visible on profile
    Keywords: This Field IS visible on profile Information for: Keywords : These keywords, describing your company, market sector or technology will enable other registered users of the website to make contact with you more easily. Separate each keyword with a comma.
     
    * This Field is required This Field is required | This Field IS visible on profile This Field IS visible on profile | This Field IS NOT visible on profile This Field IS NOT visible on profile | Information for: ? : Field description: Move mouse over icon Field description: Move mouse over icon
  • Search
Text size
  • Increase font size
  • Default font size
  • Decrease font size
HOME arrow Life Sciences arrow R&D costs multiply losses for cell regeneration firm arrow Registration
R&D costs multiply losses for cell regeneration firm
Written by Sam Fountain   
Tuesday, 18 March 2008
ImageCambridge cell therapy specialist, Intercytex has posted widened losses for the year to December, after expanded clinical trials took R&D costs up by 12 per cent.

The Cambridge based developer of regenerative medicine products to restore skin and hair said that pre-tax loss had widened to £11.6m, up from a restated £9.2m last year, driven by increased research and development costs which rose to £9.62m.

It said that the year had been a successful one, despite the widened loss, and featured a £12m placing in May, along with a comprehensive supply agreement signed with Baxter Healthcare for use of Tisseel in Intercytex's ICX-PRO and ICX-SKN products.

The year also saw a $200k (£100k) milestone payment from Bosley under its ICX-TRC option, and the company posted cash and equivalents of £12.5m at the end of December.

"We now have a maturing portfolio of assets focused on skin and hair all demonstrating exciting clinical efficacy in large and growing markets," said CEO, Nick Higgins.

"Regenerative medicine, the restoration and repair of human tissues and organs, has the potential to revolutionise the treatment of patients, and as the data continues to be reported for each of our products with highly encouraging results, it underscores the potential of our technology and the value of Intercytex in the rapidly developing field of regenerative medicine."

Shares in the firm remained static at 51p.
Trackback(0)
Comments (0)Add Comment

Write comment
This content has been locked. You can no longer post any comment.

busy
 
< Prev   Next >

Email bulletin

Enter your email address:

Delivered by FeedBurner

Featured Blog

CandidCapital blogs
  • Of Budgets and White Papers

    The 2008 UK Budget may have been a modest affair, but published with it were two documents with probably greater implications for the long-term performance of the innovation sector in the UK.

    Many of you reading through the coverage of Alistair Darling’s first Budget, delivered on 12th March 2008, may have been reminded of Claud Cockburn’s famous (spoof?) entry for the prize of most dull but accurate headline: ‘Small Earthquake in Chile, Not Many Dead’.

    read more